Science Explorer Back to mapMap
Discussion
Researcher · Agios Pharmaceuticals (United States) · United States

Katharine E. Yen

Katharine E. Yen publishes mostly in Hematology, Molecular Biology and Cancer Research, on topics such as Acute Myeloid Leukemia Research, Cancer, Hypoxia, and Metabolism and Glioma Diagnosis and Treatment.

ORCID 0000-0003-2054-9108 OpenAlex
World rank
#147,862
of 7,710,434 ranked researchers
Rank in United States
#55,819
of 1,627,098
Works
125
Citations
18k
Citations per work
145.2
h-index
37
i10-index 63Top 7.5% in Hematology
Katharine E. Yen

What does Katharine E. Yen research?

Katharine E. Yen's work is mostly in Medicine (44%), Biochemistry, Genetics and Molecular Biology (36%).

Health Sciences: 55 works · 43.7% of their workMedicine: 55 works · 43.7% of their workHematology: 26 works · 20.5% of their workGenetics: 17 works · 13.6% of their workOncology: 6 works · 4.8% of their workRadiology, Nuclear Medicine and Imaging: 6 works · 4.8% of their workLife Sciences: 45 works · 35.9% of their workBiochemistry, Genetics and Molecular Biology: 45 works · 35.9% of their workMolecular Biology: 25 works · 20.1% of their workCancer Research: 20 works · 15.8% of their workEverything else: 25 works · 20.4% of their workTHEIR WORKKatharine E. Yen125works
Life Sciences36%Health Sciences44%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine5543.7%
    1. Biochemistry, Genetics and Molecular Biology4535.9%
  3. Everything else2520.4%
  1. 1Hematology20% of their works
  2. 2Molecular Biology20% of their works
  3. 3Cancer Research16% of their works
  4. 4Genetics14% of their works
  5. 5Oncology5% of their works
  6. 6Radiology, Nuclear Medicine and Imaging5% of their works

Research topics

Which keywords describe Katharine E. Yen's research?

The keywords of their largest research topics: Acute Myeloid Leukemia, AML, Glioblastoma, HIF-1, Temozolomide, Warburg Effect, Cancer Genomics and Mutational Signatures.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 16 words, with their numbers
  1. AML421 topic
  2. Acute Myeloid Leukemia421 topic
  3. Glioblastoma251 topic
  4. HIF-1251 topic
  5. Temozolomide251 topic
  6. Warburg Effect251 topic
  7. Cancer Genomics181 topic
  8. Mutational Signatures181 topic
  9. DNA Methylation161 topic
  10. Histone Modification161 topic
  11. HDAC Inhibitors131 topic
  12. Histone Deacetylases131 topic
  13. JAK2 Mutation101 topic
  14. Myelofibrosis101 topic
  15. BCR-ABL71 topic
  16. Imatinib71 topic

Where does Katharine E. Yen work?

Katharine E. Yen's main affiliation in the publication record is Agios Pharmaceuticals (United States), United States.

How many publications and citations does Katharine E. Yen have?

OpenAlex counts 125 works and 18,152 citations for Katharine E. Yen, an h-index of 37, ranking #147,862 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Katharine E. Yen. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.